Get in on Candel Therapeutics Inc’s (CADL) buy-in window today!

With 2.45 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.03 million shares. The 52-week range on CADL shows that it touched its highest point at $14.60 and its lowest point at $1.34 during that stretch. It currently has a 1-year price target of $18.00. Beta for the stock currently stands at -1.23.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CADL was up-trending over the past week, with a rise of 26.30%, but this was up by 57.09% over a month. Three-month performance surged to 143.49% while six-month performance rose 98.67%. The stock gained 501.72% in the past year, while it has gained 20.62% so far this year. A look at the trailing 12-month EPS for CADL yields -1.74 with Next year EPS estimates of -1.08. For the next quarter, that number is -0.21. This implies an EPS growth rate of -15.27% for this year and 28.48% for next year. EPS is expected to decline by -1.01% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -46.75%.

Float and Shares Shorts:

At present, 32.13 million CADL shares are outstanding with a float of 30.51 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CADL since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.465 being high and -$1.465 being low. For CADL, this leads to a yearly average estimate of -$1.465.